Collins Aerospace has joined an aviation coalition which has jointly donated $400,000 to support Covid-19 vaccine donations in 92 countries.

The company will join AerCap, Pratt & Whitney and SMBC Aviation Capital in a group effort to support equitable access to Covid-19 vaccinations in low-income countries via a collective contribution to the Gavi COVAX Advanced Market commitment. COVAX AMC provides access to donor-funded vaccine doses to lower-income nations. In addition, the Gavi Matching Fund will double the impact of this gift, resulting in $800,000 USD in support of global COVID-19 vaccine equity.

Each company contributed $100,000 as a commitment to giving people across the globe safe and equitable access to vaccination. The current Aviation Coalition partners are encouraging others in the sector to join and learn more about Gavi and COVAX.

“In everyone’s interest to ensure the equitable distribution of vaccines”

Aengus Kelly, CEO, AerCap said: “We at AerCap are delighted to support Gavi and COVAX AMC. Though parts of the world are recovering well, other areas continue to face considerable challenges. We need to continue to support the battle against COVID-19 all across the world. It is in everyone’s interest to ensure the equitable distribution of vaccines and to support those who are less fortunate.”

Colin Mahoney, President, Customer & Account Management, Collins Aerospace added: “By supporting COVAX AMC, we can help enable access to doses of safe and effective COVID-19 vaccines in low- and middle-income countries, regardless of income level. Collins Aerospace recognises that this pandemic isn’t over until every country recovers, and COVAX is the best way for us to support.”

Rick Deurloo, Senior Vice President & Chief Commercial Officer, Pratt & Whitney, called on other aviation leaders to join the coalition in support of Gavi and COVAX AMC.

“Global solution to a global crisis”

Peter Barrett, Chief Executive Officer, SMBC Aviation Capital called for action to ensure everyone can have “equal access to safe vaccines regardless of where they live or their means. This is a global solution to a global crisis and one that we are proud to support.”

Subscribe to the FINN weekly newsletter